Home Seattle Genetics Initiates Two Phase I Trials Of SGN-CD19A
 

Keywords :   


Seattle Genetics Initiates Two Phase I Trials Of SGN-CD19A

2013-02-06 10:00:00| drugdiscoveryonline News Articles

Seattle Genetics, Inc. recently announced the initiation of two phase I clinical trials of SGN-CD19A, one for patients with B-cell acute lymphoblastic leukemia (ALL) and one for patients with B-cell non-Hodgkin lymphomas

Tags: phase seattle trials genetics

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
01.07Tropical Storm Chris Update Statement
01.07Summary for Tropical Storm Chris (AT3/AL032024)
01.07Boeing to get 'sweetheart deal' -victims' lawyer
01.07Tropical Storm Chris Graphics
01.07Hurricane Beryl Forecast Discussion Number 10
01.07Tropical Storm Chris Forecast Discussion Number 2
01.07Tropical Storm Chris Wind Speed Probabilities Number 2
01.07Tropical Storm Chris Public Advisory Number 2
More »